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 Abstract  21 
Introduction-The influence of physical activity (PA) and physical fitness (PF) at older ages 22 
on changes in telomere length (TL), repetitive DNA sequences that may mark biologic aging, 23 
is not well-established.  Few prior studies have been conducted in older adults, these were 24 
mainly cross-sectional, and few evaluated PF.  25 
Methods-We investigated cross-sectional and prospective associations of PA and PF with 26 
leukocyte TL among 582 older adults  (age 73±5 y at baseline) in the Cardiovascular Health 27 
Study, having serial TL measures and PA and PF assessed multiple times.  Cross-sectional 28 
associations were assessed using multivariable repeated-measures regression, in which 29 
cumulatively averaged PA and PF measures were related to TL. Longitudinal analyses 30 
assessed cumulatively averaged PA and PF against later changes in TL; and changes in 31 
cumulatively averaged PA and PF against changes in TL.  32 
Results-Cross-sectionally, greater walking distance and chair test performance, but not other 33 
PA and PF measures, were each associated with longer TL (p-trend=0.007, 0.04 respectively). 34 
In longitudinal analyses, no significant associations were observed between PA and PF with 35 
change in TL. In contrast, changes in leisure-time activity and chair test performance were 36 
each inversely associated with changes in TL.  37 
Conclusions-Cross-sectional analyses suggest that greater PA and PF are associated with 38 
longer TL. Prospective analyses show that changes in PA and PF are associated with 39 
differences in changes in TL. Even so, even later in life, changes in certain PA and PF 40 
measures are associated with changes in TL, suggesting that leisure-time activity and fitness 41 
could reduce leukocyte telomere attrition among older adults. 42 
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Introduction 47 
Telomere length (TL), repetitive sequences of DNA placed at the ends of eukaryotic 48 
chromosomes that act as “caps” protecting genomic integrity and stability (46), has received 49 
attention as a potential marker of biologic aging. (4, 20) Leukocyte TL in humans has been 50 
associated with age-related diseases, disease biomarkers and mortality.(4, 5, 9, 11, 12, 30, 32)  51 
For example, in the Cardiovascular Health Study, shorter TL was associated with higher risk 52 
of CVD, with age-related disease burden and mortality. (5, 11, 12, 32)   53 
Shortening of TL may be predominantly influenced by oxidative stress and 54 
inflammation.(33) It has been hypothesized that higher levels of physical activity (PA) and 55 
physical fitness (PF) may delay TL shortening, potentially through anti-inflammatory and 56 
anti-oxidative mechanisms.(22, 41) Greater PA and PF are consistently associated with lower 57 
morbidity and mortality from chronic diseases (1), supporting a potential “anti-aging” effect.  58 
Yet, only limited epidemiologic evidence supports an influence on PA or PF on TL.  Among 59 
prior studies, some observational(7, 8, 17, 18, 21, 28, 34, 48) and 1 intervention (26) studies 60 
suggested favorable roles of PA or PF for TL profiles, but other observational (6, 47) and 61 
intervention (36, 42) studies did not. In addition, all of the observational studies assessed only 62 
cross-sectional associations of a single PA or PF measure, limiting conclusions on long-term, 63 
cumulative PA or PF.  The 2 interventional studies were also of short duration (3-6 months), 64 
limiting inference on effects of long-term PA or PF.  No prior studies separately measured 65 
both PA and PF and assessed whether each of PA and PF was independently associated with 66 
TL. For example 2 of 4 prior studies had small samples sizes (N<65), limiting statistical 67 
power to detect associations; and none separately evaluated both PA and PF to determine 68 
their potential independent associations with TL.  Finally, few of these prior studies were 69 
conducted in older adults (18, 28, 34, 47), a particularly relevant population in which to study 70 
aging since old age is associated with a high prevalence of chronic diseases and consequently 71 
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a possibly accelerated rate of telomere shortening. A recent 6-month randomized controlled 72 
physical activity trial in 68-year-old, sedentary and overweight subjects, suggested that 73 
reduced siting time, but not greater time spent exercising, was associated with telomere 74 
lengthening. (38) However, this study had a small sample size (N=49). (38) 75 
To address these issues and determine whether long-term PA and PF are associated with 76 
TL and TL attrition later in life, we investigated the cross-sectional and prospective 77 
associations of PA and PF with TL in a community-based cohort study of older US adults.   78 
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Methods  79 
Population 80 
 The design and recruitment of the Cardiovascular Health Study have been 81 
described.(13, 44) Briefly, 5,201 ambulatory, non-institutionalized men and women 82 
≥65 years of age were randomly selected and enrolled from Medicare eligibility lists 83 
in 4 US communities in 1989-90; and an additional 687 black participants were 84 
similarly recruited and enrolled in 1992. The institutional review committee at each 85 
center approved the study, and all participants provided informed consent. From 86 
1989-90 to 1998-99 participants were followed by annual study visits. Standardized 87 
evaluations included physical examination, diagnostic testing, laboratory evaluation, 88 
and questionnaires on health status, medical history, and cardiovascular risk 89 
factors.(13, 27, 44) Blood was collected and stored during most visits, and DNA 90 
collected from those participants that provided consent to use genetic material. 91 
Individuals from each enrollment phase were included in the present study if they 92 
consented the use of their DNA, had at least 12 mg DNA available, had stored 93 
leukocytes for additional DNA preparation, and had measures of PA and PF info at 94 
baseline. Characteristics of individuals included in this analysis were generally similar 95 
to the whole cohort.  96 
 97 
Assessment of PA and PF 98 
PA was assessed at multiple serial visits (Supplementary Figure 1, SDC, 99 
Timeline).  Usual leisure-time activity was assessed using a modified, validated 100 
Minnesota Leisure-Time Activities questionnaire, which has been associated with risk 101 
of multiple disease outcomes in this cohort. (23) The questionnaire evaluated 102 
frequency and duration of 15 different activities during the prior 2 weeks, including 103 
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gardening, mowing, raking, swimming, hiking, aerobics, tennis, jogging, racquetball, 104 
walking, golfing, bicycling, dancing, calisthenics, and exercise cycling.(37) Each 105 
activity was defined as having an intensity value in metabolic equivalent task (MET) 106 
units,(43) and participant responses regarding types, frequency, and duration of each 107 
activity were used to calculate weekly energy expenditure (kcal/week) from leisure-108 
time activity. Usual exercise intensity was also assessed, with responses including no 109 
exercise or low, medium, or high intensity of exercise.(37) Usual walking habits, 110 
including average walking pace (gait speed), and distance walked, were assessed 111 
annually at each follow-up visit. We evaluated these metrics in pre-specified 112 
categories, including: usual pace walked (<2, 2-3 and >3 mph), blocks walked 113 
(quintiles), exercise intensity (none, low, medium and high) and leisure-time activity 114 
(quintiles). A previously defined walking score was also evaluated based on the 115 
combination of walking pace and walking distance.(23)  116 
PF was also assessed at multiple serial visits (Supplementary Figure 1, SDC, 117 
Timeline), including based on 15-ft walk (sec), grip strength (kg) and chair stands 118 
(sec).  In the 15-ft walk, a trained examiner measured the time needed for each 119 
participant to walk a 15-ft course (4.5m) at his or her usual pace.  Grip strength was 120 
measured in the dominant hand using a hand-held JAMAR dynamometer, recording 121 
the force in kg for the best of 3 attempts at maximal squeeze. For the chair stand, a 122 
trained examiner recorded how quickly each participant performed 5 consecutive 123 
chair stands (standing up, with arms folded across the chest, from a seated position on 124 
a 45-cm-tall chair), timed to the nearest tenth of 1 sec.  We evaluated each PF 125 
measure separately and, similar to the walking score, also constructed a summary 126 
measure based on all 3 PF measures (each in quintiles) to better capture the full 127 
variation of PF within the cohort.  128 
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 129 
Measurement of telomere length  130 
TL (kilo base pairs, kbp) was measured as the mean length of the terminal 131 
restriction fragments in peripheral leukocytes.(4, 11, 25) A total of 582 older adults 132 
consented for DNA preparation and use, had at least 12 g of available DNA, and had 133 
stored leukocytes for additional DNA preparation in both 1992-93 and 1997-98 and 134 
were included in the present analysis of TL change.  TL was measured using the 135 
Southern blot method as previously described.(3, 25) Each sample was analyzed twice 136 
on different gels on different occasions, with mean value used for statistical analyses. 137 
The Pearson correlation coefficient for these duplicates was 0.97, with mean CV for 138 
pair sets of 1.5%. The laboratory conducting the TL measurements was blinded to all 139 
participant characteristics.  140 
DNA integrity was assessed through electrophoresis of 0.5 g of DNA on 1.0 141 
ethidium bromide. These measures suggested some degradation, which would 142 
attenuate the ability to detect differences in TL changes over time, especially over 143 
only 5 years (1992-93 to 1997-98). 144 
 145 
Covariates 146 
 Information on a wide range of covariates was obtained during study visits, including 147 
demographics, education, income, detailed smoking habits, alcohol use, usual dietary 148 
habits, body mass index (BMI), medication use, hypertension, diabetes and presence 149 
or absence of coronary heart disease, congestive heart failure.(13) Body mass index 150 
was calculated as weight (kg)/height (m)
2
. Hypertension status was defined as either 151 
not present (systolic blood pressure <140 mmHg and diastolic blood pressure <90 152 
mmHg and no use of antihypertensive medication), borderline (systolic pressure 140–153 
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159 mmHg or diastolic pressure 90–94 mmHg and no use of antihypertensive 154 
medication), or definite (systolic pressure ≥160 mmHg or diastolic pressure ≥95 155 
mmHg or use of antihypertensive medication). Diabetes mellitus was classified using 156 
the American Diabetes Association criteria (21) as not present, impaired fasting 157 
glucose, or definite diabetes. Myocardial infarction was diagnosed using an algorithm 158 
including cardiac symptoms as chest pain, abnormal cardiac enzyme concentrations, 159 
and serial electrocardiogram changes. Fatal CHD included deaths not meeting criteria 160 
for myocardial infarction if occurring within 72 h of chest pain or with previous 161 
history of ischemic heart disease. CHD includes MI, angina, angiplasty, bypass and 162 
death due to atheroscleriotic. Strokes were classified as ischemic if there was 163 
evidence of focal brain deficit without evidence of primary hemorrhage; hemorrhagic 164 
if there was bloody spinal fluid on lumbar puncture or evidence of blood in the 165 
subarachnoid space, ventricles, or parenchyma on brain imaging or at surgery or 166 
autopsy that did not appear consistent with hemorrhage into an infarction; or 167 
unknown type if information was insufficient for classification.(19) CVD was defined 168 
as combined incident stroke, fatal and nonfatal MI and coronary heart disease death.  169 
 170 
Statistical Analysis 171 
Cross-sectional associations of PA and PF with TL were assessed using 172 
multivariable repeated-measures linear regression, utilizing measures of TL in both 173 
1992-93 and 1997-98 and accounting for within-person correlation. To minimize 174 
misclassification (measurement error) and also better represent long-term effects of 175 
habitual PA and PF, we took advantage of repeated measures of PA to PF to perform 176 
cumulative updating (averaging of serial values) (Supplementary Figure 1, SDC, 177 
Timeline).  When PA or PF were missing, the existing values were carried forward. 178 
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Cumulatively averaged PA and PF measures from 1989-93 were related to TL in 179 
1992-93; and cumulatively averaged PA and PF from 1993-98 were related to TL in 180 
1997-98. PA measures were assessed as categorical (indicator) variables; with tests 181 
for trend evaluated by entering PA categories as ordinal variables.  182 
Longitudinal analyses of PA and PF with TL change were assessed using 183 
multivariable  linear regression.  Cumulatively averaged PA and PF from 1989-93 184 
were related to the subsequent change in TL between 1992-93 and 1997-98; and 185 
changes in cumulatively averaged PA and PF between 1989-93 and 1993-98 were 186 
related to changes in TL between 1992-93 and 1997-98. The TL rate of change was 187 
calculated in bp/year, as (LTL1997-98 – LTL1992-93)/follow-up years.  188 
To minimize confounding, we adjusted models for major demographic factors 189 
including age, sex, race, study enrollment site, education, income, smoking status, and 190 
usual dietary habits, including consumption of total energy, omega-3 polyunsaturated 191 
fatty acids, omega-6 polyunsaturated fatty acids, and dietary fiber.(6, 10) We also 192 
evaluated factors which could be plausible biologic intermediates (i.e., on the putative 193 
causal pathway between PA and TL), including, body-mass index, waist 194 
circumference, fasting glucose, insulin, inflammatory markers, prevalent diseases, 195 
including T2DM and CVD.   196 
In additional analyses, we evaluated both PA and PF measures in the same model 197 
to assess their independent associations with TL. To minimize the possibility of 198 
reverse causation (poor health causing low PA/PF), we performed sensitivity analyses 199 
restricted to participants reporting only good, very good, or excellent overall health 200 
and also having no limitation in activities of daily living or instrumental activities. 201 
Because in some participants (45%) the measured change in TL was positive 202 
(potentially representing measurement error, given that TL is not generally expected 203 
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to increase), we also performed sensitivity analyses evaluating change in TL as a 204 
binary variable (any attrition, yes/no) and as a continuous variable but with any 205 
observed increases recoded as 0 (no change). We assessed potential interaction by age, 206 
sex, race and BMI by including a cross-product term of each potential modifier and 207 
each PA/PF measure in the regression model, evaluating significance of interaction 208 
using the Wald test.  Analyses were performed using Stata 10.0 (College Station, Tx), 209 
two-tailed alpha=0.05. 210 
211 
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Results 212 
 213 
At baseline, mean age was 73±5 years, and 62 % of participants were women 214 
(Table 1). About 1 in 5 participants had prevalent CHD, and 1 in 7 had prevalent 215 
diabetes. Participants spent an average of 1045±1446 kcal per week on leisure-time 216 
activities and 35% engaged in moderate intensity PA.  On average, participants 217 
walked 41±65 blocks per week, with 67% having a pace above 2 mph. The mean time 218 
needed to complete a distance of 15 ft and 5 chair stands was 5.5±2.0 and 14.8±4.9 219 
seconds, respectively. Additionally, the mean hand grip strength was of 27.5±9.8 kg.  220 
Overall at baseline, TL ranged from 5.1 to 8.6 kb, with mean±SD of 6.3±0.6 kb 221 
and median 6.3 kb. Mean TL change, calculated as TL1997-98-TL1992-93, was -222 
0.012±0.18 kb between 1992-93 and 1997-98, an annualized attrition of -2.44 bp/year.  223 
 224 
Cross-sectional analysis of PA and PF and TL 225 
In cross-sectional multivariable-adjusted analyses, greater reported walking 226 
distance and a better chair test performance were associated with longer TL (p-227 
trend=0.007 and 0.04 respectively) (Table 2). Additionally, a better overall fitness 228 
score was associated with a trend toward longer TL (p-trend=0.09). In contrast, 229 
walking pace, leisure-time activity, time to complete a 15-ft walk, and hand grip 230 
strength were not significantly associated with TL. Analysis included only 231 
participants with excellent, very good and good health status and those with no 232 
limitations in activities of daily living or instrumental activities generated similar 233 
results.  234 
 235 
Longitudinal analysis of PA and PF and change in TL   236 
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In multivariable longitudinal analyses, no significant associations were observed 237 
between PA and PF from 1989-93 and subsequent 5-year change in TL (Table 3). 238 
Results including only participants with good or better health status and without 239 
limitations in activities of daily living or instrumental activities were generally similar. 240 
In secondary analyses evaluating change in TL as a binary variable (attrition, yes/no) 241 
or as a continuous variable but with any observed increases re-coded as 0, no 242 
significant associations were observed between PA and PF from 1989-93 and 243 
subsequent 5-year change in TL (Supplementary Table 1 and 2, SDC, additional 244 
statistical analyses).  245 
 246 
Longitudinal analysis of changes in PA and PA and change in TL  247 
When we evaluated changes in PA and PF and changes in TL, change in leisure-248 
time activity was associated with a trend toward less shortening in TL (p-trend=0.07), 249 
and change in chair test performance was associated with less shortening in TL (p-250 
trend=0.04). For example, each 1000 kcal/week of increased leisure-time activity was 251 
associated with a trend toward 2.2 bp/year less attrition (95%CI: -0.18, 4.6); and each 252 
one second change in the time needed to complete 5 chair stands was associated with 253 
0.9 bp/year less attrition in TL (95% CI: 0.04 1.8).  Other PA measures such as 254 
walking pace, walking distance and walking score, and other PF measures such as the 255 
walk test, hand grip test, and overall PF score, were not significant associated with 256 
change in TL. When we excluded participants with poor self-reported health status or 257 
having any limitations in activities of daily living or instrumental activities, 258 
associations of changes in leisure-time activity and chair test performance with 259 
change in TL were strengthened in magnitude (2.8 bp/year and 1.2 bp/year, 260 
respectively) and statistical significance (p-trend=0.04 and 0.02, respectively). Results 261 
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were generally similar in sensitivity analyses recoding any observed increases in TL 262 
to no change (Supplementary Table 3, SDC, additional statistical analyses). 263 
 264 
Results were not appreciably altered in several sensitivity analyses, including 265 
further adjustment for both PA and PF measures to assess their independent 266 
associations with TL or further adjustment for baseline characteristics that could be 267 
either confounders or mediators of these relationships (see Methods). Additionally, 268 
we performed cumulative averaging with 50% weight given to most recent PA/PF 269 
measure, with similar results to the equal weight cumulative averaging (data not 270 
shown).  271 
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Discussion  272 
In this large prospective study among older adults, average age 73 years at their 273 
first measurement of TL, cross-sectional analyses suggested that greater walking 274 
distance as well as chair test performance are associated with longer TL. Furthermore, 275 
prospective analyses have shown that changes in leisure-time activity and in chair test 276 
performance are associated with differences in change in TL.  The lack of prospective 277 
associations of other PA and PF metrics could be due to measurement error in TL due 278 
to DNA degradation, which would have diminished the ability to detect changes. 279 
Even so, even later in life, changes in certain PA and PF are associated with TL, 280 
suggesting that greater leisure-time activity and fitness could reduce leukocyte 281 
attrition among older adults.  282 
Telomeres are cap-like nucleoproteins at chromosome ends, which protect genome 283 
from degradation and interchromosomal fusion(16, 35). In the normal cellular process, 284 
a small portion of telomeric DNA is lost with each cell division, when a limit length is 285 
achieved cell undergoes apoptosis.(35) Normally with aging chromosomes become 286 
increasingly impaired due to DNA damage, eventually leading to apoptotic signals 287 
and cell death; however, telomeres can prevent or delay such damage.(16) It has been 288 
hypothesized that certain lifestyles factors may accelerate telomere shortening and 289 
consequently affect health, healthy aging, and longevity.(35)  Shorter TL is associated 290 
with several age-related diseases, (39) including cardiovascular diseases and  type 2 291 
diabetes.(11) Our observed findings of longer telomeres with some measures of 292 
greater PA and PF at baseline and less telomere attrition with some measures of 293 
changes in PA and PF longitudinally suggest that PA and PF could influence 294 
pathways related to TL.  Such an effect could, for example, partly account for the 295 
beneficial associations of PA and PF with many age-related diseases. (39) (35) 296 
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Biologic plausibility of our findings is supported by the putative pathways of telomere 297 
loss, which are thought to be related to cumulative burdens of oxidative stress and 298 
inflammation (2, 14), and the pathways of benefits of regular PA, which include 299 
upregulation of antioxidant defense systems (15) and reduced chronic systemic 300 
inflammation. (41) By these and other pathways, PA may reduce oxidative DNA 301 
damage; (33, 39) for example, duration of exercise has been inversely correlated with 302 
biomarkers for DNA and telomere damage and with p16 expression, a biomarker for 303 
cellular aging.(39) Interestingly, a bout of acute exercise increases production of free 304 
radicals, dependent on intensity and duration.(15) This pro-oxidant response may be 305 
necessary for activation of beneficial anti-oxidant and other cellular defense systems 306 
(29), by means of which habitual, long-term PA, such as we evaluated in this study, 307 
may lead to beneficial physiological adaptations.(15)  308 
Another possible explanatory pathway might be through an upregulation of 309 
telomerase reverse transcriptase that seems to occur after exercise. (14) For example, 310 
mechanisms for beneficial effects of omega-3 fatty acids and PA on survival after 311 
acute myocardial infarction could relate to elevation in telomerase expression, 312 
resulting in higher regeneration potential (31, 45). Although controversial, some 313 
evidence suggests that leucocyte TL could actually elongate over a decade (24); 314 
however, others believe that apparent elongation is mainly due to measurement error 315 
(40).  No consensus seems to exist concerning this potential for lengthening of 316 
telomeres; further studies on this topic are needed. 317 
In the present work we observed similarities and differences in cross-sectional 318 
versus prospective analyses as for example, walking distance but not leisure-time 319 
activity in cross-sectional analyses was associated with longer TL; conversely in 320 
prospective analyses leisure-time activity but not walking distance was associated 321 
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with differences in change in TL. Interestingly, chair test was associated with both 322 
cross-sectional and prospective analyses. The reasons for these specific associations 323 
are unknown and our novel findings highlight the need for further investigation of 324 
how different types of PA and different measures of PF may influence TL.   325 
The American College of Sports Medicine and American Heart Association 326 
recommend that older adults engage in at least in 30 min of moderate PA on most 327 
days of the week.(1) Our results support these general guidelines by suggesting that 328 
long-term PA may influence telomere dynamics later in life.  329 
Previous studies of PA and TL have provided inconsistent results; and only 4 were 330 
conducted in older adults. (18, 28, 34, 47) Of these, one cross-sectional study among 331 
2,006 older Chinese participants reported no association between PA and TL(47); the 332 
other 3 studies, also cross-sectional but conducted in much smaller samples (N=32 to 333 
204), found positive associations between PA and TL.(18, 28, 34) Our results are 334 
consistent with these latter 3 cross-sectional studies and also with other cross-335 
sectional studies, conducted among middle age and younger participants, linking 336 
higher PA to longer TL.(7, 8, 17, 18, 21, 28, 34, 48) Our findings build upon and 337 
expand these previous results by evaluating both cross-sectional and longitudinal 338 
associations of PA, PF and TL, including changes in both, in a well-established cohort 339 
of older US adults.   340 
Our analysis had several strengths. Information on PA, PF, TL and other risk 341 
factors was prospectively assessed using standardized methods. Participants were 342 
randomly selected and enrolled from Medicare eligibility lists in several US 343 
communities, providing a community-based sample of older adults. Serial measures 344 
of PA allowed evaluation of cumulatively updated PA, reducing misclassification and 345 
providing a better measure of longer-term PA.  Serial measures also allowed the novel 346 
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evaluation of how changes in PA relate to changes in TL. Prospective analyses as well 347 
as sensitivity analyses excluding less healthy participants reduced the potential for 348 
reverse causation, and adjustment for a wide range of covariates minimized the 349 
potential impact of confounding. 350 
Potential limitations were also present. Measurement error in TL, and in particular 351 
TL change, would diminish the ability to detect associations, which would cause 352 
underestimation of the magnitude and statistical significance of our findings. 353 
Additionally, the TL quantification technique used is a less sensitive method to 354 
identify subtle differences between individuals and requires high-quality DNA. We 355 
evaluated several different PA and PF indices, increasing the possibility of chance 356 
findings. However, several of our findings are consistent with other studies; and one 357 
could consider each PA or PF and TL association a separate hypothesis.  Borderline p 358 
values should be interpreted with caution, with careful attention to both internal 359 
consistency and biological plausibility. PA measures were obtained from self-report, 360 
and may appropriately reflect relative ordering (ranking) of participants but not 361 
precise quantitative levels of energy expenditure. Although a range of covariates were 362 
available and evaluated as potential confounders and findings were similar in 363 
sensitivity analyses, residual confounding due to unknown or incompletely measured 364 
factors cannot be excluded. The assessments of PA, PF, and TL were subject to 365 
random error and biological variability, which would attenuate findings toward the 366 
null. The prospective associations of cumulatively updated PA with TL could also 367 
partly reflect the effects of PA earlier in life; in contrast, the associations of changes 368 
in PA with TL would not be confounded by PA at younger ages.  Different 369 
participants had different number of exposure measures and thus possible different 370 
precision of the exposure. Results were attained from older, predominantly white 371 
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Americans and may not be directly generalizable to other populations. Furthermore, 372 
our results may only be generalized to leukocyte TL, since it may not reflect TL 373 
dynamics in other tissues.  Conversely, leukocyte TL is the most commonly measured 374 
TL metric, and has been associated with diverse exposures and disease endpoints in 375 
prior studies.  376 
In sum, our results suggest that greater walking distance and chair test 377 
performance are cross-sectionally associated with longer TL; and that changes in 378 
leisure-time activity and in chair test performance are associated with differences in 379 
change in TL. These results suggest that PA and PF may have a role in the regulation 380 
of telomere length during the aging process.  381 
  382 
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Table 1. Baseline (1992-93) characteristics of 582 older US adults in the Cardiovascular Health Study 548 
with longitudinal assessment of physical activity, physical fitness and telomere length.  549 
Characteristic  
Age, years 73±5 
Gender, % male 38 
Race, % white  85 
Education   
< High school, % 24 
High school, % 32 
> High school, % 43 
Annual income ≥ $25,000, % 39 
Smoking habits  
Former smoker, % 44 
Current smoker, % 10 
Body mass index, kg/m² 27±5 
Prevalent coronary heart disease, % 20 
Prevalent congestive heart failure, %  5 
Prevalent diabetes mellitus, % 14 
Physical activity   
Walking pace, mph  
< 2, % 33 
> 2, % 67 
Walking blocks, blocks/week  41±65 
Exercise intensity 
 
 
None, % 8 
Low, % 45 
Moderate, %  35 
High, % 12 
Leisure-time activity, kcal/week 1045±1446 
Physical fitness   
Walk test, sec/15 ft 5.5±2.0 
Hand grip test, kg 27.5±9.8 
Chair test, sec/5 chair stands 14.8±4.9 
Values are mean ± SD (continuous variables) or percentage (categorical variables). 550 
Coronary heart disease=history of myocardial infarction, angina, or coronary revascularization. 551 
Congestive Heart Failure = according to the presence of following symptoms: sleep on 2 pillows to 552 
breathe, awakened at night by trouble breathing, swelling of feet and ankles during the day which goes 553 
down overnight.  Diabetes =fasting glucose >140 mg/dl, two hour post-oral challenge glucose >200 554 
mg/dl, or use of insulin or oral hypoglycemic medications. 555 
556 
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Table 2. Multivariable-adjusted cross-sectional associations in cumulatively averaged physical activity 557 
and physical fitness, between 1989-90 and 1992-93 and between 1993-94 and 1997-98, with telomere 558 
length, from1992-93 and 1997-98, among 1164 older US adults. 559 
  Telomere Length, (95% CI), base pairs * 
 
All participants  
Excluding participants 
with poor or fair 
self-reported health status 
Excluding participants 
with limitations in  
activities of 
 daily living 
N=582 N=458 N=438 
Physical Activity**    
Walking pace, mph    
      < then 2 reference reference reference 
       2-3  9.5 (-18.3, 37.4) 10.2 (-21.6, 42.0) 11.6 (-21.1, 44.3) 
> then 3 -19.5 (-67.3, 28.3) -14.1 (-66.6, 38.5) -19.8 (-72.1, 32.5) 
       P trend 0.78 0.86 0.72 
Walking distance, blocks/week    
≤ 5 reference  reference reference 
6 to 13 33.0 (-6.6, 72.6) 54.7 (8.2, 101.2) 17.3 (-32.6, 67.2) 
14 to 27 36.9 (-6.9, 80.8) 62.6 (12.6, 112.4) 17.8 (-35.6, 71.2) 
28 to 54 46.2 (-1.4, 91.8) 66.6 (13.9,119.3) 24.9 (-30.4, 80.1) 
≥55 
P trend 
79.4 (27.6, 131.3) 
0.007 
109.6 (50.7, 168.6) 
0.002 
60.0 (-0.4, 120.4) 
0.06 
Walking Scoreδ     
  I reference reference reference 
 II  17.9 (-26.9, 62.8) 23.2 (-32.3, 78.6) 28.9 (-28.1, 85.9) 
 III 4.3 (-53.1, 61.7)  22.1 (-44.9, 89.0) 17.8 (-51.4, 87.0) 
 IV 13.3 (-34.7, 61.4) 38.6 (-19.9, 97.1) 28.0 (-30.9, 86.9) 
 V 18.7 (-29.4, 66.8) 37.1(-21.8,96.1) 30.2(-28.8, 89.1) 
P trend 0.54 0.95 0.49 
Intensity    
None  reference reference   reference 
Low 28.4 (-14.8, 71.6) 6.0 (-47.6, 59.6) 24.1 (-32.2, 80.3) 
Moderate 32.9 (-12.7, 78.6) 10.6 (-44.4, 65.6) 35.6 (-23.5, 94.7) 
High 58.4 (-4.1, 120.9) 35.9 (-34.7, 106.4) 79.0 (4.2, 153.9) 
P trend 0.12 0.33 0.04 
Leisure-time activity, kcal/week    
<104 reference reference  reference 
105 to 420  34.9 (-4.5, 74.5) 31.9 (-14.3, 78.0) 59.2 (9.9, 108.5) 
431 to 875 28.9 (-15.5, 73.4) 27.4 (-24.4, 79.2) 47.6 (-6.7, 101.8) 
889 to 1740 35.3 (-11.4, 82.1) 34.6 (-19.3, 88.6) 44.2 (-13.7, 102.1) 
≥1761 38.8 (-11.1, 88.7) 35.6 (-20.5, 91.8) 61.8 (2.4, 121.2) 
P trend 0.21 0.39 0.31 
Physical Fitness**    
Walk test , sec/15 ft Ŧ     
≥6.7 reference reference reference 
6.5 to 5.7   16.2 (-11.9, 8.7) 10.5 (-37.9, 58.8) 14.5 (-33.0, 62.0) 
5.5 to 5.0 37.5 (-10.3, 8.5) 41.1 (-11.9, 94.1) 50.7 (-1.6, 103.1) 
4.7 to 4.3 46.1 (-6.9, 14.2) 51.7 (-4.4, 107.7) 47.2 (-9.0, 103.4) 
4.0 to 3.0 31.5 (-15.1, 7.5) 33.2 (-29.3, 95.6) 25.4 (-37.6, 88.4) 
P trend 0.20 0.18 0.41 
Hand grip test, kgŦ     
<19.6 reference reference reference 
19.7 to 23.6 -13.9 (-56.4, 28.6) -24.0 (-69.1, 21.1) -5.8 (-53.4, 41.7) 
23.7 to 28.8 -1.6 (-56.4, 53.3) -27.3 (-85.8, 31.3) 21.9 (-41.4, 85.4) 
29.1 to 37.1 20.1 (-47.5, 87.6) -3.5 (-76.7, 69.6) 42.2 (-35.8, 120.2) 
≥37.3 37.9 (-52.9, 128.7) 12.2 (-85.7, 110.1) 35.9 (-66.7, 138.5) 
P trend 0.47 0.95 0.36 
 Chair test, sec/5 chair stands Ŧ     
≥17.0 reference reference reference 
16.7 to 14.0   -2.9 (-41.2, 35.3) -16.3 (-60.3, 27.7) -18.5 (-61.3, 24.3) 
13.7 to 12.3   8.5 (-34.5, 51.5) 8.4 (-40.6, 57.3) 2.6 (-44.6, 49.8) 
12.0 to 10.7   29.7 (-15.2, 74.6) 34.9 (-15.2, 84.9) 18.7 (-31.3, 68.6) 
<10.6 39.8 (-7.3, 86.9)  41.2 (-11.8, 94.1) 21.9 (-29.5, 73.4) 
P trend 0.04 0.02 0.18 
Physical fitness score  Ŧ δ     
I reference reference reference 
II -11.6 (-50.7, 27.4) -31.7 (-78.2, 14.8) -22.9 (-70.0, 24.2) 
III 8.8 (-35.9, 53.6) -18.5 (-72.6, 35.7) 1.0 (-52.7, 54.8) 
IV 35.1 (-14.9, 85.1)       16.6 (-42.3, 75.5) 20.0 (-38.6, 78.6) 
V 31.9 (-28.5, 92.3) 9.8 (-60.3, 80.0) 13.5 (-54.42, 80.7) 
P trend 0.09 0.18 0.29 
* All analyses adjusted for age (years), gender (male/female), race (white/nonwhite), clinical site (4 560 
categories), education (< high school, high school > high school), income (≤/> $ 25 000/year) and 561 
smoking status (never/former/current). 562 
28 
 
 563 
** Cross-sectional (mix-model) analysis according to physical activity and physical fitness cumulative 564 
average between 1997-98 and 1992-93. 565 
δ 
Walking score is an ordinal score based on the combination of walking pace and walking distance. 566 
Physical fitness score is an ordinal score based on the combination of performances on the walk test, 567 
hand grip test and chair test (each in quintiles). 568 
Ŧ 
Sample size included ~ 25-40 fewer participants in each analysis due to missing data on the exposure. 569 
570 
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Table 3. Multivariable-adjusted longitudinal associations in cumulatively averaged physical activity 571 
and physical fitness, between 1989-93, with changes in telomere length, between 1992-93 and 1997-98, 572 
among 582 older US adults. 573 
Telomere Length, (95% CI), base pairs per year* 
 
All participants  
Excluding participants 
with poor or fair 
self-reported health 
status 
Excluding participants 
with limitations in 
activities of 
daily living 
N=582       N=458       N=438 
Physical Activity 
**
    
Walking pace, mph    
< then 2 reference reference reference 
2-3  1.2  (-6.2, 8.4) 3.1  (-5.7, 12.0) 6.5 (-3.0, 16.0) 
> then 3 -2.8 (-12.5, 6.8) -0.6 (-11.8, 10.5) 2.9 (-8.6, 14.3) 
P trend 0.62 0.88 0.74 
Walking distance, blocks/week    
≤ 5  reference reference reference 
6 to 13 -2.5 (-12.3, 7.2) -3.9 (-15.3, 7.6) -0.8 (-13.2, 11.5) 
14 to 27 7.4 (-2.2, 16.9) 6.0 (-5.1, 17.1) 12.7 (0.9, 24.4) 
28 to 54 -1.4 (-10.9, 8.2) -2.8 (-12.9, 8.3) -0.3 (-11.8, 11.2) 
≥55 3.3 (-6.4, 13.0) 3.1 (-7.9, 14.3) 3.9 (-7.6, 15.3) 
P trend 0.50 0.56 0.69 
Walking score 
δ     
I reference reference reference 
II 0.6 (-12.0 13.3) 1.5 (-15.2, 18.1) 3.4 (-14.6, 21.4) 
III 2.7 (-9.2, 14.5) 6.2 (-9.7, 22.1) 12.3 (-4.4, 28.9) 
IV 4.0 (-6.9, 14.9) 5.4 (-9.3, 20.2) 11.4 (-4.1, 26.9) 
V 3.5 (-8.2, 15.2) 6.2 (-9.1, 21.5) 9.2 (-6.9, 25.2) 
P trend 0.43 0.36 0.28 
Intensity    
None  reference reference reference 
Low -8.7 (-24.3, 6.8) -9.5 (-28.6, 9.6) -11.5 (-34.1, 11.2) 
Moderate -9.4 (-24.9, 6.2) -10.4 (-29.4, 8.6) -14.3 (-36.9, 8.3) 
High -0.3 (-17.9, 17.3) 0.8 (-20.1, 21.6) -3.4 (-27.7, 20.9) 
P trend 0.59 0.44 0.76 
Leisure-time activity, kcal/week    
≤104 reference reference reference 
105 to 420 -2.3 (-11.6, 7.1) 0.6 (-10.4, 11.6) -1.2 (-13.0, 10.6) 
431 to 875 4.2 (-5.4, 13.7) 7.5 (-3.6, 18.7) 3.2 (-8.6, 15.1) 
889 to 1740 4.3 (-5.4, 14.0) 5.7 (-5.4, 16.9) 5.9 (-6.2, 18.0) 
≥1761 -1.9 (-11.8, 7.9) 0.5 (-10.6, 11.6) -2.2 (14.1, 9.7) 
P trend 0.83 0.78 0.98 
Physical Fitness 
**
    
Walk test, sec/15 ft
Ŧ 
    
≥6.7 reference reference reference 
6.5 to 5.7   -1.6 (-11.9, 8.7) 1.6 (-10.6, 13.8) 2.4 (-11.4, 16.2) 
5.5 to 5.0 -0.9 (-10.3, 8.5) 0.3 (-10.6, 11.2) 4.1 (-8.7, 16.9) 
4.7 to 4.3 3.6 (-6.9, 14.2) 4.5 (-7.3, 16.3) 9.6 (-4.2, 23.4) 
4.0 to 3.0 3.8 (-15.1, 7.5) -1.7 (-14.4, 10.9) 0.7 (-13.8, 15.1) 
P trend 0.94 0.99 0.62 
Hand grip test, kg
Ŧ 
    
≤19.6 reference reference reference 
19.7 to 23.6 5.0 (-4.4, 14.4) 1.7 (-8.8, 12.1) 7.8 (-3.3, 18.9) 
23.7 to 28.8 10.7 (1.1, 20.3) 6.3 (-4.3, 16.9) 12.8 (0.9, 24.7) 
29.1 to 37.1 8.6 (-2.9, 20.2) 4.7 (-7.8, 17.2) 6.7 (-7.4, 20.8) 
≥37.3 9.7 (-4.4, 23.7) 3.8 (-11.5, 19.1) 11.9 (-5.3, 29.1) 
P trend 0.07 0.41 0.13 
 Chair test, sec/5 chair stands
Ŧ 
    
≥17.0 reference reference reference 
16.7 to 14.0   -1.4 (-10.9, 8.1) 2.9 (-7.2, 12.9) 1.6 (-8.9, 12.1) 
13.7 to 12.3   -2.9 (-12.5, 6.6) -3.9 (-14.2, 6.4) -2.0 (-12.7, 8.6) 
12.0 to 10.7   2.7 (-6.6, 12.1) 4.1 (-6.1, 14.4) 4.2 (-6.4, 14.7) 
≤10.6 -3.2 (-13.4, 6.9) 0.7 (-10.5, 11.9) -2.5 (-14.4, 9.4) 
P trend 0.93 0.78 0.98 
Physical fitness score
 Ŧ  δ     
   I reference reference reference 
II 3.5 (-6.4, 13.5) 1.9 (-10.2, 13.9) 4.7 (-8.7, 18.0) 
III 4.1 (-5.8, 13.9) 0.2 (-11.5, 11.9) 4.7 (-8.6, 17.9) 
IV 2.2 (-8.3, 12.7) 2.9 (-9.4, 15.3) 4.1 (-9.7, 17.9) 
   V -0.2 (-13.1, 12.8) -1.6 (-16.7, 13.4) 3.4 (-12.6, 19.3) 
P trend 0.94 0.99 0.84 
*  Rate of change in TL (bp/year) = (TL1997-98 – TL1992-93 )/follow-up years. Positive values indicate 574 
lesser shortening in telomere length according to comparison to reference group, whereas negative 575 
values indicate greater shortening in telomere length.  All analyses adjusted for age (years), gender 576 
(male/female), race (white/nonwhite), clinical site (4 categories), education (< high school, high school, 577 
> high school), income (≤/> $25 000/year) and smoking status (never/former/current).  578 
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** 
Longitudinal analysis according to physical activity and physical fitness cumulative average of 1989-579 
90, 1990-91, 1991-92, 1992-93 (or the ones available). 580 
δ
 Walking score is an ordinal score based on the combination of walking pace and walking distance. 581 
Physical fitness score is an ordinal score based on the combination of performances on the walk test, 582 
hand grip test and chair test (each in quintiles). 583 
Ŧ 
Sample size included ~ 25-40 fewer participants in each analysis due to missing data on the exposure. 584 
585 
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Table 4.  Multivariable-adjusted associations of changes in cumulatively averaged physical activity 586 
and physical fitness between 1989-93 and 1993-98 with changes in telomere length between 1992-93 587 
and 1997-98 among 582 older US adults. 588 
                                                 Differences in Telomere Length, (95% CI), base pairs per year* 
 
All 
participants 
 
Excluding participants 
with poor or fair 
self-reported health status 
Excluding participants 
with limitations in 
activities of 
daily living 
N=582 N=458 N=438 
Physical Activity 
**    
Change in walking pace, per each higher mph 
(≤-2: 3.3%; -1.5 to -1: 24.3%; 0.5: 15.0%; 0: 44.6%; 0.5: 
6.9%; ≥1: 5.9%)*** 
-0.6 (-4.9, 3.7) -2.0 (-6.9, 2.8) -3.2 (-8.2,1.7) 
 0.78 0.41 0.20 
 
Change in walking distance, per higher blocks/week  
(mean± SD: -7.7 ± 33.5; 10
th
 percentile: -42.1 ; 90
th
 
percentile: 22.1) 
0.04 (-0.05, 0.13) -0.01 (-0.10, 0.1) 0.06 (-0.03, 0.15) 
 0.40 0.90 0.19 
 
Change in walking score, per 1 higher unit
δ  
(≤-1.3: 4.1%; -1: 20%; -0.75 to -0.25: 5.7%; 0: 50.8%; 
0.27to 0.74: 3.4%; ≥ 2: 16%)*** 
-1.6 (-5.5, 2.2) -3.1 (-7.5, 1.3) -0.7 (-5.1, 3.8) 
 0.41 0.17 0.76 
 
Change in leisure-time activity, per higher 
1000kcal/week 
 (mean± SD: -345.9 ± 1238.8; 10
th
 percentile: -1653.8 ; 
90
th
 percentile: 735) 
2.2 (-0.18, 4.6) 2.3 (-0.20, 4.8) 2.8 (0.15, 5.4) 
 0.07 0.07 0.04 
Physical Fitness 
**
    
Change in walk test, per 1 higher sec/15 ft
Ŧ  
 (mean± SD: 0.4±1.9; 10
th
 percentile: -0.9; 90
th
 
percentile: 1.8)
 
0.2 (-1.4, 1.8) 0.5 (-1.2, 2.3) 2.1 (-0.5,4.6) 
 0.80 0.56 0.11 
 
Change in hand grip test, per higher kg
Ŧ 
 
 (mean± SD: -0.6 ± 3.6; 10
th
 percentile: -5.0 ; 90
th
 
percentile: 3.7) 
0.4 (-0.5, 1.3) 0.4 (-0.6, 1.4) 0.3 (-0.7, 1.3) 
 0.37 0.41 0.60 
  
Change in chair test, per 1 higher sec/5 chair stands
Ŧ 
 
0.9 (0.04, 1.8) 1.1 (0.5, 2.2) 1.2 (0.2, 2.2) 
 (mean± SD: 2.2 ± 3.6; 10
th
 percentile: -1.7 ; 90
th
 
percentile: 6.5) 
0.04 0.04 0.02 
 
Change in physical fitness score, per 1 higher unit
Ŧ  δ  
(≤-1: 18.7%; 0: 43.9%; ≥1: 37,4%)*** 
-2.2 (-6.0, 1.6) -2.7 (-6.8, 1.3) -2.4 (-6.6, 1.7) 
 0.25 0.19 0.25 
*  Rate of change in TL (bp/year) = (TL1997-98 – TL1992-93 )/follow-up years. Positive values indicate 589 
lesser shortening in telomere length, whereas negative values indicate greater shortening in telomere 590 
length.  All analyses adjusted for age (years), gender (male/female), race (white/nonwhite), clinical site 591 
(4 categories), education (< high school, high school, > high school), income (≤/> $25 000/year) and 592 
smoking status (never/former/current).  593 
**Longitudinal analysis according to physical activity and physical fitness cumulative average 594 
difference between 1997-98 and 1992-93. 595 
*** Categories of change, and the proportion of participants in each category 596 
δ
 Walking score is an ordinal score based on the combination of walking pace and walking distance. 597 
Physical fitness score is an ordinal score based on the combination of performances on the walk test, 598 
hand grip test and chair test (each in quintiles). 599 
Ŧ 
Sample size included ~ 25-40 fewer participants in each analysis due to missing data on the exposure. 600 
